Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 916

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening

Open access
Quintero, Enrique, Castells, Antoni, Bujanda, Luis, Cubiella, Joaquín, Salas, Dolores, Lanas, Ángel, Andreu, Montserrat, Carballo, Fernando, Morillas, Juan Diego, Hernández, Cristina, Jover, Rodrigo, Montalvo, Isabel, Arenas, Juan, Laredo, Eva, Hernández, Vicent, Iglesias, Felipe, Cid, Estela, Zubizarreta, Raquel, Sala, Teresa, Ponce, Marta, Andrés, Mercedes, Teruel, Gloria, Peris, Antonio, Roncales, María-Pilar, Polo-Tomás, Mónica, Bessa, Xavier, Ferrer-Armengou, Olga, Grau, Jaume, Serradesanferm, Anna, Ono, Akiko, Cruzado, José, Pérez-Riquelme, Francisco, Alonso-Abreu, Inmaculada, de la Vega-Prieto, Mariola, Reyes-Melian, Juana Maria, Cacho, Guillermo, Díaz-Tasende, José, Herreros-de-Tejada, Alberto, Poves, Carmen, Santander, Cecilio, González-Navarro, Andrés·2012·New England Journal of Medicine

Abstract

BACKGROUND: Colonoscopy and fecal immunochemical testing (FIT) are accepted strategies for colorectal-cancer screening in the average-risk population. METHODS: In this randomized, controlled trial involving asymptomatic adults 50 to 69 years of age, we compared one-time colonoscopy in 26,703 subjects with FIT every 2 years in 26,599 subjects. The primary outcome was the rate of death from colorectal cancer at 10 years. This interim report describes rates of participation, diagnostic findings, and occurrence of major complications at completion of the baseline screening. Study outcomes were analyzed in both intention-to-screen and as-screened populations. RESULTS: The rate of participation was higher in the FIT group than in the colonoscopy group (34.2% vs. 24.6%, P<0.001). Colorectal cancer was found in 30 subjects (0.1%) in the colonoscopy group and 33 subjects (0.1%) in the FIT group (odds ratio, 0.99; 95% confidence interval [CI], 0.61 to 1.64; P=0.99). Advanced adenomas were detected in 514 subjects (1.9%) in the colonoscopy group and 231 subjects (0.9%) in the FIT group (odds ratio, 2.30; 95% CI, 1.97 to 2.69; P<0.001), and nonadvanced adenomas were detected in 1109 subjects (4.2%) in the colonoscopy group and 119 subjects (0.4%) in the FIT group (odds ratio, 9.80; 95% CI, 8.10 to 11.85; P<0.001). CONCLUSIONS: Subjects in the FIT group were more likely to participate in screening than were those in the colonoscopy group. On the baseline screening examination, the numbers of subjects in whom colorectal cancer was detected were similar in the two study groups, but more adenomas were identified in the colonoscopy group. (Funded by Instituto de Salud Carlos III and others; ClinicalTrials.gov number, NCT00906997.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1108895

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 916

Metadata

Authors
Quintero, E., Castells, A., Bujanda, L., Cubiella, J., Salas, D., Lanas, Á., Andreu, M., Carballo, F., Morillas, J. D., Hernández, C., Jover, R., Montalvo, I., Arenas, J., Laredo, E., Hernández, V., Iglesias, F., Cid, E., Zubizarreta, R., Sala, T., Ponce, M., Andrés, M., Teruel, G., Peris, A., Roncales, M.-P., Polo-Tomás, M., Bessa, X., Ferrer-Armengou, O., Grau, J., Serradesanferm, A., Ono, A., Cruzado, J., Pérez-Riquelme, F., Alonso-Abreu, I., de la Vega-Prieto, M., Reyes-Melian, J. M., Cacho, G., Díaz-Tasende, J., Herreros-de-Tejada, A., Poves, C., Santander, C., & González-Navarro, A.
Venue
New England Journal of Medicine
Published
2012-02-23
Volume
366
Issue
8
Pages
697-706
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2118256990
Cited by
916
References
37
FWCI
38.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. https://app.cochat.ai/papers/10.1056/nejmoa1108895
The paper
Quintero, E., Castells, A., Bujanda, L., Cubiella, J., Salas, D., Lanas, Á., Andreu, M., Carballo, F., Morillas, J. D., Hernández, C., Jover, R., Montalvo, I., Arenas, J., Laredo, E., Hernández, V., Iglesias, F., Cid, E., Zubizarreta, R., Sala, T., . . . González-Navarro, A. (2012). Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1108895

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.